BioNTech

Category

Independent Aventiv Research Selected by Pfizer & BioNTech for COVID-19 Vaccine Trial: Volunteers Drive 2 Hours to Contribute

Independently-owned Columbus Ohio-based Aventiv Research was selected by the Pfizer/BioNTech “Project Lightspeed” program to participate in the Phase 2/3 clincial trial to test the RNA-based COVID-19 vaccine. With involvement of 120 sites around the world, this...

UC Davis Health Ramps Up Project Lightspeed: Serves as Trial Site for Phase 2/3 BNT162 COVID-19 Vaccine Study

UC Davis Health was one of about 120 trial sites selected worldwide to participate in the Phase 2/3 stage testing of the COVID-19 vaccine candidate known as BTN162, developed by Germany’s BioNTech and Pfizer Inc. The addition of this pivotal clinical trial adds even a...

Upstate Medical University Selected by “Project Lightspeed” & Treats First Four Patients with BNT162 COVID-19 Vaccine

Upstate Medical University was selected by the Pfizer and BioNTech partnership to participate in the Phase 3 clinical trial assessing the safety and efficacy of the German company’s BNT162 vaccine targeting the novel coronavirus. Four vaccines in the BNT162 portfolio,...

Pfizer/BioNTech Select North Alabama Research Center & Sister Site Medical-Affiliated Research Center for Phase 3 BNT162 COVID-19 Vaccine Trial

North Alabama Research Center (NARC) and a sister site called Medical-Affiliated Research Center of Huntsville gear up to conduct major COVID-19 vaccine clinical trials sponsored by the BioNTech and Pfizer partnership. The site operation and study is overseen by Tonya...

Pin It on Pinterest